~~<i id='0FA14622C0'><strike id='0FA14622C0'><tt id='0FA14622C0'><pre id='0FA14622C0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

comprehensive

author：entertainment 2025-09-06 04:37:07 - browse：632

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Precocious puberty in girls comes with mental health risks

Wikipedia

explore

knowledge

focus

hotspot

knowledge

MollyFergusonforSTATZariawasjust9yearsoldwhenanursepractitionerdeliverednewsthatrockedherworld:Theyo

WSS

UnitedHealth’s board chair also owns a personal investment firm

Senate committee scrutinizes Medicare Advantage brokers

STAT Summit: Michael J. Fox on progress in Parkinson's research

Why health workers in Gaza are injured or die at high rates

Novo Nordisk obesity pill bests Wegovy in early trial

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Wikipedia

comprehensive

Featured Speakers

Wikipedia

Hollywood unions extend contract negotiations for actors

Sen. Paul opposes bill to ban Chinese biotechs

Affirmative action in medical school literally saved lives

First medicine developed to treat MASH expected to be approved soon

How to save PrEP access — and even expand it

Change Healthcare cyberattack prompts Medicare loan program

Tori Bowie and the unacceptable rates of Black maternal death

STAT Summit: Biotech founders on deal

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

explore

The drug industry has found itself all alone in Washington

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

STAT Summit: Biotech founders on deal

First Opinion Podcast: Long Covid needs a new approach

A deep dive into Applied Therapeutics’ data, and questions on Cassava

HHS leader on health, climate change and biopharma emissions

knowledge

focus

hotspot

knowledge